Sonoma Keeps You Informed

Sign up for email alerts to receive Sonoma updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Upcoming Events

2024 Annual Meeting of Stockholders

Aug 14, 2024 • 2:00pm MDT

View All Events

Latest Financial Results

FY 2024

Fiscal Year Ended Mar 31, 2024

Latest Annual Filing

Fiscal Year Ended Mar 31, 2024

View Filing

Stock Information

Company Overview

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions. The company's products, which are sold throughout the world, have improved outcomes for more than ten million patients globally by reducing infection, itch, pain, scarring and harmful inflammatory responses. Sonoma’s headquarters are in Woodstock, Georgia, with manufacturing operations in Jalisco, Mexico. European marketing and sales are headquartered in Roermond, Netherlands.
Sonoma Investor Presentation April 2024

Sonoma Investor Presentation April 2024

Download Sonoma Investor Presentation April 2024


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Sonoma Pharmaceuticals, Inc.
5445 Conestoga Court
Suite 150
Boulder, CO 80301
T: 800-759-9305

Investor Relations

T: 470-938-1011

Transfer Agent

462 South 4th Street
Suite 1600
Louisville, KY 40202
T: 888-647-8901